Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon
Thumbnail

PCSK9 inhibitors lower cholesterol, but is cost a concern?

The FDA’s approval of the first proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor brought about excitement for some with regards to the effectivenss of the new class of drugs in lowering cholesterol. It also raised concerns about the high costs associated with the medications.

Costs of PCSK9 inhibitors may be prohibitive

With the pending approval of two cholesterol-lowering drugs, the Washington Post reports concerns are mounting about the costs of the medications, which are both injectable proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. 

Thumbnail

Compensation for cardiologists increased in 2014

In 2014, the median compensation increased approximately 7.5 percent for a general cardiologist and 8.0 percent for a cardiologist working in the cath lab, according to an American Medical Group Association (AMGA) survey released on July 14. Meanwhile, compensation for cardiac or thoracic surgeons increased 4.8 percent from the previous year.

Thumbnail

Statins are cost-effective based on ACC/AHA guidelines

When the American College of Cardiology (ACC) and American Heart Association (AHA) released guidelines in November 2013 for primary prevention of cardiovascular disease, healthcare professionals questioned the threshold for prescribing statins. However, researchers found the threshold used in the ACC/AHA guidelines fit an acceptable cost-effectiveness profile.

Thumbnail

Novartis plans strategy to offset high cost of new heart failure drug

Novartis CEO Joe Jimenez told the Wall Street Journal that the company is considering offering add-on healthcare services to insurers concerned with the high costs of its newest drug. 

Thumbnail

Medtronic makes another deal, agrees to acquire RF Surgical Systems for $235 million

Medtronic has signed a definitive agreement to acquire RF Surgical Systems, a company that develops a system to detect and prevent surgical items left inside patients after wound closure. The deal was for $235 million.

Edwards Lifesciences to acquire CardiAQ Valve Technologies for $400 million

Edwards Lifesciences announced on July 10 that it had agreed to acquire CardiAQ Valve Technologies, the developer of an investigational transcatheter mitral valve replacement system. The deal was valued at up to $400 million, including $350 million in cash.

ACC applauds House approval of the 21st Century Cures Act

The U.S. House of Representatives passed the 21st Century Cures Act (H.R. 6), voting 344-77 in favor of the legislation aimed at accelerating drug discoveries and approvals and promoting research collaboration.

Displaying 1297 - 1304 of 1706

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.